These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 69882)

  • 1. Elevation of plasma-prolactin by monoamine-oxidase inhibitors.
    Slater SL; Lipper S; Shiling DJ; Murphy DL
    Lancet; 1977 Aug; 2(8032):275-6. PubMed ID: 69882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man.
    Murphy DL; Lipper S; Slater S; Shiling D
    Psychopharmacology (Berl); 1979 Apr; 62(2):129-32. PubMed ID: 111275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative behavioral effects of clorgyline and pargyline in man: a preliminary evaluation.
    Lipper S; Murphy DL; Slater S; Buchsbaum MS
    Psychopharmacology (Berl); 1979 Apr; 62(2):123-8. PubMed ID: 111274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between cytosolic monoamine oxidase and spin-labeled amphetamine and its modification by clorgyline and pargyline.
    Copeland ES; Campbell IC; Murphy DL
    Biochim Biophys Acta; 1983 Feb; 743(1):186-94. PubMed ID: 6824699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
    Fowler CJ; Oreland L; Callingham BA
    J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain.
    Campbell IC; Robinson DS; Lovenberg W; Murphy DL
    J Neurochem; 1979 Jan; 32(1):49-55. PubMed ID: 32233
    [No Abstract]   [Full Text] [Related]  

  • 7. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
    Fowler CJ; Mantle TJ; Tipton KF
    Biochem Pharmacol; 1982 Nov; 31(22):3555-61. PubMed ID: 6817759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of mitochondrial monoamine oxidase of the rat uterus and liver by clorglyine, pargyline and harmine.
    Grosso DS; Gawienowski AM
    Biochem Pharmacol; 1976 Apr; 25(8):957-61. PubMed ID: 178322
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoamine oxidase inhibitors potentiate phenylethylamine effects in rhesus monkeys.
    Staub RA; Gillin JC; Wyatt RJ
    Biol Psychiatry; 1980 Jun; 15(3):429-36. PubMed ID: 6769508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the monoamine oxidase inhibitors clorgyline and pargyline on the hyperphagia of obese mice.
    Feldman JM
    Behav Brain Res; 1988 Jul; 29(1-2):147-58. PubMed ID: 2840925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with clorgyline and pargyline differentially decreases clonidine-induced hypotension and bradycardia.
    Gutkind JS; Enero MA
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):189-92. PubMed ID: 6493360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic clorgyline and pargyline increase apomorphine-induced stereotypy in the rat.
    Campbell IC; Durcan MJ; Cohen RM; Pickar D; Chugani D; Murphy DL
    Pharmacol Biochem Behav; 1985 Dec; 23(6):921-5. PubMed ID: 4080777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain monoamine oxidase in suckling rabbits treated with organophosphorus compound. I. Acute intoxication.
    Maślińska D
    Acta Physiol Pol; 1984; 35(2):137-40. PubMed ID: 6443171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
    Barbelivien A; Nyman L; Haapalinna A; Sirviö J
    Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of monoamine oxidase inhibitors and a dopamine uptake blocker on the distribution of 11C-N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 11C-MPTP, in the head of the rhesus monkey.
    Hartvig P; Larsson BS; Lindberg BS; Oreland L; Gullberg P; Långström B; Rimland A; Lundqvist H; Malmborg P; Lindquist NG
    Acta Neurol Scand; 1986 Jul; 74(1):10-6. PubMed ID: 3490110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pehidine interaction with clorgyline, pargyline, or 5-hydroxytryptophan: lack of enhanced pethidine lethality or hyperpyrexia in mice.
    Leander JD; Batten J; Hargis GW
    J Pharm Pharmacol; 1978 Jun; 30(6):396-8. PubMed ID: 26781
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid.
    Major LJ; Murphy DL; Lipper S; Gordon E
    J Neurochem; 1979 Jan; 32(1):229-31. PubMed ID: 759576
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
    Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
    Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of low-dose clorgyline on 24-hour urinary monoamine excretion in patients with rapidly cycling bipolar affective disorder.
    Linnoila M; Karoum F; Potter WZ
    Arch Gen Psychiatry; 1982 May; 39(5):513-6. PubMed ID: 6178382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REM sleep suppression induced by selective monoamine oxidase inhibitors.
    Cohen RM; Pickar D; Garnett D; Lipper S; Gillin JC; Murphy DL
    Psychopharmacology (Berl); 1982; 78(2):137-40. PubMed ID: 6817370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.